3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes.
Blum
Arnon
A
Department of Internal Medicine A, Poria Medical Center, Lower Galilee 15208, Israel. navablum@hotmail.com
Simsolo
Claudia
C
Hasin
Yonathan
Y
D015906:Angioplasty, Balloon, Coronary; D001161:Arteriosclerosis / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control; D023903:Coronary Restenosis / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D017202:Myocardial Ischemia / Q000517:prevention & control
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids